Dec'04 | Dec'05 | Dec'06 | Dec'07 | Dec'08 | Dec'09 | Dec'10 | Dec'11 | Dec'12 | Dec'13 | Dec'14 | Dec'15 | Dec'16 | Dec'17 | Dec'18 | Dec'19 | Dec'20 | Dec'21 | Dec'22 | Dec'23 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
EPS | $2.6 | $3.2 | $2.6 | $2.6 | $2.0 | $3.1 | $2.8 | $5.2 | $3.6 | $3.5 | $4.5 | $5.3 | $7.8 | $6.3 | $11.0 | $10.3 | $11.1 | $21.5 | $19.4 | $19.2 |
Discover the top 20 best undervalued stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued large-cap growth stocks to buy for Feb 2025, listed on the Nasdaq or NYSE.
Discover the top 20 best undervalued high-yield dividend stock that offers both growth potential and attractive dividend returns for Feb 2025.
As of today, HCA Healthcare, Inc.'s last 12-month EPS is $22.2, based on the financial report for Dec 31, 2024 (Q4 2024).
Over the last year, HCA Healthcare, Inc.'s EPS growth was 14.9%. The average annual EPS growth rates for HCA Healthcare, Inc. have been 14.4% over the past three years, 16.6% over the past five years.